OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117967	Articles
99398	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 06/12/2025 at 08:30, 5 months 23 days ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
PRESS RELEASE

published on 06/12/2025 at 08:30, 5 months 23 days ago

Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis
Oxurion NV meldet die Erfüllung der aufschiebenden Bedingung hinsichtlich des Informations- und Konsultationsrechts der Arbeitnehmer für die Übernahme von Axiodis CRO. Oxurion konzentriert sich auf die Fertigstellung der Transaktion und beschleunigt Gespräche mit anderen strategischen Zielen zur Schaffung von Synergien in der Region Toulouse

Übernahme Toulouse Oxurion NV Synergien Axiodis CRO
BRIEF

published on 06/11/2025 at 18:05, 5 months 24 days ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 06/11/2025 at 18:05, 5 months 24 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/11/2025 at 18:00, 5 months 24 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen met betrekking tot aankoop en verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven, België. Meer informatie op www.oxurion.com

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Aankoop Aandelen Verkoop Aandelen
PRESS RELEASE

published on 06/11/2025 at 18:00, 5 months 24 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages

Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF

published on 06/04/2025 at 18:05, 6 months 1 day ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Special Opportunities Notification De Transparence Oxurion Législation Belge
BRIEF

published on 06/04/2025 at 18:05, 6 months 1 day ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Legislation
PRESS RELEASE

published on 06/04/2025 at 18:00, 6 months 1 day ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en blijft onder drempel van 5%. Bedrijf combineert therapeutische innovatie met technologieën in klinisch onderzoek

Transparantiekennisgeving Aandelen Oxurion NV Biofarmaceutisch Innovatie
PRESS RELEASE

published on 06/04/2025 at 18:00, 6 months 1 day ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV has received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in shareholding, crossing under the 5% threshold

Clinical Research Transparency Notification Biopharmaceutical Shareholding Change Oxurion NV

Accesswire

Published on 12/06/2025 at 00:25, 8 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 33 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 3 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 43 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 48 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 2 hours 17 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 20 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 34 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 6 hours 6 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 6 hours 17 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 33 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 33 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 33 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 33 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 14 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE